Antibody-onconase conjugates: cytotoxicity and intracellular routing

August 5, 2008 | Comments Off on Antibody-onconase conjugates: cytotoxicity and intracellular routing

Current Pharmaceutical Biotechnology. 2008 Jun;9(3):226-30. Link Rybak SM. Bionanomics, LLC, 411 Walnut Street, Green Cove Springs, FL 32043, USA. rybak@mindspring.com Abstract Onconase, a member of the pancreatic ribonuclease A superfamily,…

Antibody-targeted RNase fusion proteins (immunoRNases) for cancer therapy

August 5, 2008 | Comments Off on Antibody-targeted RNase fusion proteins (immunoRNases) for cancer therapy

Current Pharmaceutical Biotechnology. 2008 Jun;9(3):231-4. Link Krauss J, Arndt MA, Dübel S, Rybak SM. Natinal center for tumor diseases (NCT), Universit6y of Heidelberg, Im Neuenheimer Fild 350, D-69120 Heidleberg, Germany.…

Comparison of Osteopontin, Megakaryocyte Potentiating Factor, and Mesothelin Proteins as Markers in the Serum of Patients with Malignant Mesothelioma

August 2, 2008 | Comments Off on Comparison of Osteopontin, Megakaryocyte Potentiating Factor, and Mesothelin Proteins as Markers in the Serum of Patients with Malignant Mesothelioma

Journal of Thoracic Oncology. 2008 Aug;3(8):851-7. [Link] Creaney J, Yeoman D, Demelker Y, Segal A, Musk AW, Skates SJ, Robinson BW. National Research Centre for Asbestos Related Diseases, Western Australian…

MET as a target for treatment of chest tumors

August 2, 2008 | Comments Off on MET as a target for treatment of chest tumors

Lung Cancer. 2008 Jul 29. [Epub ahead of print] [Link] Cipriani NA, Abidoye OO, Vokes E, Salgia R. Section of Hematology/Oncology, Department of Medicine, University of Chicago Medical Center, Chicago,…

Update of Potency Factors for Asbestos-Related Lung Cancer and Mesothelioma

August 1, 2008 | Comments Off on Update of Potency Factors for Asbestos-Related Lung Cancer and Mesothelioma

Critical Reviews in Toxicology. 2008 Aug 1:1. [Epub ahead of print] [Link] Berman DW, Crump KS. Aeolus, Inc., Albany, California, USA. Abstract The most recent update of the U.S. Environmental…

Imaging of primary malignant tumors of peritoneal and retroperitoneal origin

August 1, 2008 | Comments Off on Imaging of primary malignant tumors of peritoneal and retroperitoneal origin

Cancer Treatment and Research. 2008;143:281-97. [Link] Hinshaw JL, Pickhardt PJ. Department of Radiology, University of Wisconsin Medical School, Madison, WI, 53792, USA. Abstract Peritoneal carcinomatosis and metastatic involvement of the…

Establishment of a human malignant fibrous mesothelioma cell line and the biological characteristics compared with malignant epithelial mesothelioma cell line

August 1, 2008 | Comments Off on Establishment of a human malignant fibrous mesothelioma cell line and the biological characteristics compared with malignant epithelial mesothelioma cell line

Human Cell. 2008 Aug;21(3):79-87. [Link] Ishiwata I, Ishiwata E, Hirano T. Department of Obstetrics and Gynecology, School of Medicine, Jikei University, Tokyo, Japan. Abstract Two human malignant mesothelioma cell lines,…

Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors

July 30, 2008 | Comments Off on Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors

Journal of Carcinogenesis. 2008 Jul 28;7(1):3. [Epub ahead of print] [Link] Weiner SJ, Neragi-Miandoab S. Abstract Malignant pleural mesothelioma (MPM) is a rare, aggressive tumor for which no effective therapy…

Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodality therapy

July 29, 2008 | Comments Off on Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodality therapy

European Journal of Cardio-Thoracic Surgery. 2008 Jul 23. [Epub ahead of print] [Link] Nakas A, Trousse DS, Martin-Ucar AE, Waller DA. Department of Thoracic Surgery, Glenfield Hospital, Groby Road, Leicester…

Malignant Mesothelioma—A Connective Tissue Tumor with Proteoglycan-Dependent Differentiation

July 29, 2008 | Comments Off on Malignant Mesothelioma—A Connective Tissue Tumor with Proteoglycan-Dependent Differentiation

Connective Tissue Research. 2008;49(3):249-51. [Link] Hjerpe A, Dobra K. Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, Sweden. Abstract Malignant mesothelioma (MM) is a connective tissue tumor with…

Categories